A high-efficiency system of natural killer cell cloning

Journal of Immunological Methods

Volumn 307, Issue 1-2, 2005, Pages 24-33

  Morris, Rebecca J ^a   Chong, Lee K ^a   Wilkinson, Gavin W G ^a   Wang, Eddie C Y ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cloning; Natural killer cells

Indexed keywords

CD3 ANTIBODY; OKT 3;

ARTICLE; CELL CLONING; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IRRADIATION; NATURAL KILLER CELL; PRIORITY JOURNAL; STEM CELL; TECHNIQUE;

ANTIGENS, CD94; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; CLONE CELLS; COCULTURE TECHNIQUES; CULTURE MEDIA; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MUROMONAB-CD3; RECEPTORS, IMMUNOLOGIC;

EID: 29144440184     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.08.015     Document Type: Article

References (37)

1. E.M. Bluman, G.S. Schnier, B.R. Avalos, M.P. Strout, H. Sultan, F.W. Jacobson, D.E. Williams, W.E. Carson, and M.A. Caligiuri The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction Blood 88 1996 3887
2. J. Brady, Y. Hayakawa, M.J. Smyth, and S.L. Nutt IL-21 induces the functional maturation of murine NK cells J. Immunol. 172 2004 2048
3. V.M. Braud, D.S. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, L.L. Lanier, and A.J. McMichael HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C Nature 391 1998 795
4. C. Cantoni, C. Bottino, R. Augugliaro, L. Morelli, E. Marcenaro, R. Castriconi, M. Vitale, D. Pende, S. Sivori, R. Millo, R. Biassoni, L. Moretta, and A. Moretta Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells Eur. J. Immunol. 29 1999 3148
5. S. Carlens, M. Gilljam, M. Remberger, J. Aschan, B. Christensson, and M.S. Dilber Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution Exp. Hematol. 28 2000 1137
6. S. Carlens, M. Gilljam, B.J. Chambers, J. Aschan, H. Guven, H.G. Ljunggren, B. Christensson, and M.S. Dilber A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells Hum. Immunol. 62 2001 1092
7. W.H. Carr, A.M. Little, E. Mocarski, and P. Parham NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines Clin. Immunol. 105 2002 126
8. W.E. Carson, J.G. Giri, M.J. Lindemann, M.L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M.A. Caligiuri Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor J. Exp. Med. 180 1994 1395
9. W.E. Carson, S. Haldar, R.A. Baiocchi, C.M. Croce, and M.A. Caligiuri The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2 Proc. Natl. Acad. Sci. U. S. A. 91 1994 7553
10. W.E. Carson, M.E. Ross, R.A. Baiocchi, M.J. Marien, N. Boiani, K. Grabstein, and M.A. Caligiuri Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro J. Clin. Invest. 96 1995 2578
11. R. Jacobs, G. Hintzen, A. Kemper, K. Beul, S. Kempf, G. Behrens, K.W. Sykora, and R.E. Schmidt CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells Eur. J. Immunol. 31 2001 3121
12. M.T. Kasaian, M.J. Whitters, L.L. Carter, L.D. Lowe, J.M. Jussif, B. Deng, K.A. Johnson, J.S. Witek, M. Senices, R.F. Konz, A.L. Wurster, D.D. Donaldson, M. Collins, D.A. Young, and M.J. Grusby IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity Immunity 16 2002 559
13. M.K. Kennedy, and L.S. Park Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex J. Clin. Immunol. 16 1996 134
14. K.E. Langley, L.G. Bennett, J. Wypych, S.A. Yancik, X.D. Liu, K.R. Westcott, D.G. Chang, K.A. Smith, and K.M. Zsebo Soluble stem cell factor in human serum Blood 81 1993 656
15. L.L. Lanier NK cell receptors Annu. Rev. Immunol. 16 1998 359
16. R.D. Leavitt, R.L. Felsted, and N.R. Bachur Biological and biochemical properties of Phaseolus vulgaris isolectins J. Biol. Chem. 252 1977 2961
17. V. Litwin, J. Gumperz, P. Parham, J.H. Phillips, and L.L. Lanier Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type J. Exp. Med. 178 1993 1321
18. S.D. Lyman, L. James, L. Johnson, K. Brasel, P. de Vries, S.S. Escobar, H. Downey, R.R. Splett, M.P. Beckmann, and H.J. McKenna Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells Blood 83 1994 2795
19. L. Meyaard, G.J. Adema, C. Chang, E. Woollatt, G.R. Sutherland, L.L. Lanier, and J.H. Phillips LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes Immunity 7 1997 283
20. L. Moretta, and A. Moretta Unravelling natural killer cell function: triggering and inhibitory human NK receptors EMBO J. 23 2004 255
21. L. Moretta, R. Biassoni, C. Bottino, M.C. Mingari, and A. Moretta Human NK-cell receptors Immunol. Today 21 2000 420
22. A. Moretta, C. Bottino, M. Vitale, D. Pende, C. Cantoni, M.C. Mingari, R. Biassoni, and L. Moretta Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis Annu. Rev. Immunol. 19 2001 197
23. A. Nagler, L.L. Lanier, S. Cwirla, and J.H. Phillips Comparative studies of human FcRIII-positive and negative natural killer cells J. Immunol. 143 1989 3183
24. A. Nagler, L.L. Lanier, and J.H. Phillips Constitutive expression of high affinity interleukin 2 receptors on human CD-16 natural killer cells in vivo J. Exp. Med. 171 1990 1527
25. P. Parham Immunogenetics of killer cell immunoglobulin-like receptors Mol. Immunol. 42 2005 459
26. J. Parrish-Novak, S.R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J.A. Gross, J. Johnston, K. Madden, W. Xu, J. West, S. Schrader, S. Burkhead, M. Heipel, C. Brandt, J.L. Kuijper, J. Kramer, D. Conklin, S.R. Presnell, J. Berry, F. Shiota, S. Bort, K. Hambly, S. Mudri, C. Clegg, M. Moore, F.J. Grant, C. Lofton-Day, T. Gilbert, F. Rayond, A. Ching, L. Yao, D. Smith, P. Webster, T. Whitmore, M. Maurer, K. Kaushansky, R.D. Holly, and D. Foster Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function Nature 408 2000 57
27. T. Ranson, C.A. Vosshenrich, E. Corcuff, O. Richard, W. Muller, and J.P. Di Santo IL-15 is an essential mediator of peripheral NK-cell homeostasis Blood 101 2003 4887
28. M.J. Robertson, T.J. Manley, C. Donahue, H. Levine, and J. Ritz Costimulatory signals are required for optimal proliferation of human natural killer cells J. Immunol. 150 1993 1705
29. M.G. Roncarolo, M. Bigler, J.B. Haanen, H. Yssel, R. Bacchetta, J.E. de Vries, and H. Spits Natural killer cell clones can efficiently process and present protein antigens J. Immunol. 147 1991 781
30. H. Spits, and H. Yssel Cloning of human T and natural killer cells Methods 9 1996 416
31. M. Takasugi, M.R. Mickey, and P.I. Terasaki Reactivity of lymphocytes from normal persons on cultured tumor cells Cancer Res. 33 1973 2898
32. P. Tomasec, E.C. Wang, A.J. Davison, B. Vojtesek, M. Armstrong, C. Griffin, B.P. McSharry, R.J. Morris, S. Llewellyn-Lacey, C. Rickards, A. Nomoto, C. Sinzger, and G.W. Wilkinson Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141 Nat. Immunol. 6 2005 181
33. G. Trinchieri, and D. Santoli Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis J. Exp. Med. 147 1978 1314
34. M. Vales-Gomez, H.T. Reyburn, R.A. Erskine, M. Lopez-Botet, and J.L. Strominger Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E EMBO J. 18 1999 4250
35. N.M. Valiante, M. Uhrberg, H.G. Shilling, K. Lienert-Weidenbach, K.L. Arnett, A. D'Andrea, J.H. Phillips, L.L. Lanier, and P. Parham Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors Immunity 7 1997 739
36. H. Wada, N. Matsumoto, K. Maenaka, K. Suzuki, and K. Yamamoto The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues Eur. J. Immunol. 34 2004 81
37. H. Yssel, J.E. De Vries, M. Koken, W. Van Blitterswijk, and H. Spits Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones J. Immunol. Methods 72 1984 219